Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
NICE: It Takes Two to Tango
lungcanc
What’s New from the 2016 ESMO Clinical Guidelines
lungcanc
IASLC World Conference on Lung Cancer 2016 Together Against Lung Cancer
lungcanc
The Lung Master Protocol (Lung-MAP)
lungcanc
Changing Landscape of Front-line Immunotherapy
lungcanc
New Findings in Malignant Pleural Mesothelioma (MPM)
lungcanc
Glen Weiss, MD, MBA
lungcanc
David Spigel, MD
lungcanc
Mark A. Socinski, MD
lungcanc
David H. Johnson, MD
lungcanc
1
...
44
45
46
...
53
Page 45 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
